Skip to content
healthcare.dev

Trumenba

NDC 0005-0100, meningococcal group B vaccine, injection, suspension, from Wyeth Pharmaceutical Division of Wyeth Holdings LLC.

Product NDC
0005-0100
Status
Listed
Labeler
Wyeth Pharmaceutical Division of Wyeth Holdings LLC
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125549
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0005-0100 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 A05 PROTEIN VARIANT ANTIGEN60 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN60 ug/.5mL
Package NDCNDC-11Package
0005-0100-05000050100055 SYRINGE in 1 CARTON (0005-0100-05) / .5 mL in 1 SYRINGE (0005-0100-01)
0005-0100-100000501001010 SYRINGE in 1 CARTON (0005-0100-10) / .5 mL in 1 SYRINGE (0005-0100-01)

Linked data

RxNorm, label and prices

Use it

Look up 0005-0100 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0005-0100 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0005-0100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.